Yi Ding
7Patents
1h-index
32Co-inventors
47Inventor score
Filing activity: Sep 11, 2012 → Aug 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9486434B2 | Method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer | Human Necessities | 10 | Active |
| US10941204B2 | Highly potent antibodies binding to death receptor 4 | Chemistry; Metallurgy | 1 | Active |
| US11891446B2 | Highly potent antibodies binding to death receptor 5 | Chemistry; Metallurgy | 0 | Active |
| US12378299B2 | CD80 variant proteins and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12428479B2 | CLDN18.2-targeting antibody, bispecific antibody and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12011475B2 | Polypeptide, polypeptide fragment, derivative thereof, and applications thereof | Human Necessities | 0 | Active |
| US11485782B2 | Anti-claudin 18.2 antibodies | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.